Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
European Society for Human Genetics
Geneticists oppose singling out Jewish women in European patent
July 6th, 2005
Jewish women in Europe may face genetic discrimination in access to breast cancer diagnosis if the patent on the BRCA2 gene, which is currently being disputed, is not withheld by the European Patent Office (EPO), stated the European Society for Human Genetics (ESHG) in mid-June 2005. The EPO was scheduled to act on June 29, after this article went to press. The European Society for Human Genetics (ESHG) is strongly opposed to the selection of a particular racial group as a diagnostic target in a gene patent claim and is calling on the EPO to take action to prevent this situation. On June 29 the EPO was scheduled hear the...
Source: Biotech Week (2005-07-06)
|
